7th Drug Design and Medicinal Chemistry Conference

Dear Colleague,

The recent years have been an exciting time for those working in drug discovery. Collaborations between industry, academic centers and government agencies have yielded astonishing results in the development and rapid improvements of drug design, but there are still many questions. What is the future of medicinal chemistry? What are the challenges and opportunities for kinase inhibitor drug discovery? What is the role of data sharing in drug discovery today? What impact has translational medicine made in the preclinical setting?

GTC is proud to present its 7th Drug Design and Medicinal Chemistry Conference, to be held on May 8-10, 2013 at the Hyatt Regency in Boston, MA, which will provide a forum for drug discovery leaders of the future to meet and discuss these issues.

Join us as leaders in the arena of drug design and medicinal chemistry facilitate discourse on hot topics such as the rise of epigenetics as a target class, binding kinetics, and protein-protein interactions. Other topics such as fragment-based screening and design, covalent inhibitors, protein misfolding and many more will also be discussed.

Don’t miss this opportunity to meet others doing similar research, and connect with those doing work with different techniques, target classes and other areas as well!

Sessions this year include:

• Rising Targets in Drug Discovery

• Novel Methods in Drug Design

• New Computational Methods in Drug Design

• Advances in Hit-Finding Strategies